Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Zoetis

31.8% sales growth and 50.49% return on equity

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.

Zoetis’s sales growth this year is anticipated to be 11.9% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 6.67B for the twelve trailing months.

Zoetis’s sales growth for the next quarter is 31.8%. The company’s growth estimates for the present quarter and the next is 8.4% and 21.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.49%.

Volatility

Zoetis’s last day, last week, and last month’s current volatility was 0.22%, 1.46%, and 1.00%, respectively.

Zoetis’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.45% (day), 1.66% (last week), and 1.54% (last month), respectively.

Zoetis’s Stock Yearly Top and Bottom Value

Zoetis’s stock is valued at $170.35 at 23:22 EST, under its 52-week high of $176.64 and way above its 52-week low of $121.50.

Zoetis’s Moving Average

Zoetis’s value is above its 50-day moving average of $155.67 and higher than its 200-day moving average of $160.60.

Previous days news about Zoetis

According to Bloomberg Quint on Friday, 7 May, "The gains are linked to an increase in so-called curbside veterinary care, in which doctors send treatment recommendations and diagnostics via email, leading to less negotiation about treatments and prices, Zoetis CEO Kristin Peck said in an interview. ", "Since last summer, Zoetis has seen a significant increase in the adoption of dogs and cats. "

3. Advanced Semiconductor Engineering

25.8% sales growth and 14.7% return on equity

ASE Technology Holding Co., Ltd.

Advanced Semiconductor Engineering’s sales growth this year is anticipated to be 23.1% and 16.9% for next year.

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 499.09B for the twelve trailing months.

Advanced Semiconductor Engineering’s sales growth for the next quarter is 25.8%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.7%.

Volatility

Advanced Semiconductor Engineering’s last day, last week, and last month’s current volatility was 4.60%, 2.49%, and 2.33%, respectively.

Advanced Semiconductor Engineering’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.35% (day), 1.90% (last week), and 2.13% (last month), respectively.

Advanced Semiconductor Engineering’s Stock Yearly Top and Bottom Value

Advanced Semiconductor Engineering’s stock is valued at $8.19 at 23:22 EST, below its 52-week high of $9.00 and way above its 52-week low of $3.88.

Advanced Semiconductor Engineering’s Moving Average

Advanced Semiconductor Engineering’s worth is above its 50-day moving average of $7.92 and way above its 200-day moving average of $6.75.

4. Aviat Networks

11.9% sales growth and 18.89% return on equity

Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America, Africa, the Middle East, Europe, Russia, Latin America, and the Asia Pacific.

Aviat Networks’s sales growth this year is expected to be 12.1% and 6.9% for next year.

Year-on-year quarterly revenue growth grew by 26%, now sitting on 260.85M for the twelve trailing months.

Aviat Networks’s sales growth for the next quarter is 11.9%. The company’s growth estimates for the present quarter and the next is a negative 5.4% and negative -21%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.89%.

Volatility

Aviat Networks’s last day, last week, and last month’s current volatility was 0.24%, 9.25%, and 4.92%, respectively.

Aviat Networks’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.06% (day), 10.89% (last week), and 8.47% (last month), respectively.

Aviat Networks’s Stock Yearly Top and Bottom Value

Aviat Networks’s stock is valued at $29.70 at 23:22 EST, way below its 52-week high of $77.36 and way higher than its 52-week low of $8.75.

Aviat Networks’s Moving Average

Aviat Networks’s worth is way under its 50-day moving average of $63.91 and way below its 200-day moving average of $39.24.

5. Inari Medical

124.4% sales growth and 12.74% return on equity

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States.

Inari Medical’s sales growth this year is expected to be 67.6% and 26.5% for next year.

Year-on-year quarterly revenue growth grew by 144.4%, now sitting on 139.67M for the twelve trailing months.

Inari Medical’s sales growth is a negative 0% for the ongoing quarter and 124.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 0% and 125%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.74%.

Volatility

Inari Medical’s last day, last week, and last month’s current volatility was 0.32%, 3.88%, and 2.01%, respectively.

Inari Medical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.00% (day), 7.68% (last week), and 5.27% (last month), respectively.

Inari Medical’s Stock Yearly Top and Bottom Value

Inari Medical’s stock is valued at $96.23 at 23:22 EST, way below its 52-week high of $127.42 and way above its 52-week low of $39.55.

Inari Medical’s Moving Average

Inari Medical’s worth is way below its 50-day moving average of $107.72 and higher than its 200-day moving average of $92.51.

6. Ebix

69.1% sales growth and 14.1% return on equity

Ebix, Inc. provides on-demand software and e-commerce services and solutions to insurance, financial, healthcare, and e-learning industries in the United States and internationally.

Ebix’s sales growth this year is expected to be 26.3% and 8% for next year.

Year-on-year quarterly revenue growth grew by 51.9%, now sitting on 625.61M for the twelve trailing months.

Ebix’s sales growth for the next quarter is 69.1%. The company’s growth estimates for the current quarter and the next is 7.4% and 9.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.1%.

Volatility

Ebix’s last day, last week, and last month’s current volatility was 3.68%, 1.23%, and 2.13%, respectively.

Ebix’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.11% (day), 4.48% (last week), and 5.51% (last month), respectively.

Ebix’s Stock Yearly Top and Bottom Value

Ebix’s stock is valued at $28.06 at 23:22 EST, way below its 52-week high of $64.14 and way above its 52-week low of $14.70.

Ebix’s Moving Average

Ebix’s value is way below its 50-day moving average of $31.83 and way below its 200-day moving average of $32.33.

LEAVE A REPLY

Please enter your comment!
Please enter your name here